Connect with us
Efficient and advanced temperature monitoring, control and response can be achieved by pharmaceutical companies through automative processes.
Centrexion Therapeutics will allot the funding to the next phase of its CNTX-4975 drug.
Last year, there was a large increase in the demand for global hematology drugs and diagnostics.